Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
Frontiers in Immunology|October 21, 2015
Modulation of APC Function and Anti-Tumor Immunity by Anti-Cancer DrugsKea Martin, Jens Schreiner, Alfred ZippeliusCancer Immunology Research|January 28, 2015
Induced PD-L1 expression mediates acquired resistance to agonistic anti-CD40 treatmentAlfred Zippelius, Jens Schreiner, Petra Herzig, et al.The Journal of Biological Chemistry|May 31, 2012
Exploring the topology of the Gid complex, the E3 ubiquitin ligase involved in catabolite-induced degradation of gluconeogenic enzymesRuth Menssen, Jörg Schweiggert, Jens Schreiner, et al.International Journal of Medical Microbiology : IJMM|September 13, 2016
Staphylococcus aureus PSM peptides induce tolerogenic dendritic cells upon treatment with ligands of extracellular and intracellular TLRsNicole S Armbruster, Jennifer R Richardson, Jens Schreiner, et al.Frontiers in Immunology|September 27, 2019
Systematic Review of Safety and Efficacy of Rituximab in Treating Immune-Mediated DisordersCeline Kaegi, Benjamin Wuest, Jens Schreiner, et al.Inflammatory Intestinal Diseases|April 14, 2021
Clinical Relevance of Anti-TNF Antibody Trough Levels and Anti-Drug Antibodies in Treating Inflammatory Bowel Disease PatientsIlana Reinhold, Sena Blümel, Jens Schreiner, et al.Cancer Immunology, Immunotherapy : CII|June 8, 2014
The microtubule-depolymerizing agent ansamitocin P3 programs dendritic cells toward enhanced anti-tumor immunityKea Martin, Philipp Müller, Jens Schreiner, et al.Journal of Immunology (Baltimore, Md. : 1950)|March 6, 2013
Staphylococcus aureus phenol-soluble modulin peptides modulate dendritic cell functions and increase in vitro priming of regulatory T cellsJens Schreiner, Dorothee Kretschmer, Juliane Klenk, et al.Journal of Immunology (Baltimore, Md. : 1950)|January 6, 2016
PSM Peptides of Staphylococcus aureus Activate the p38-CREB Pathway in Dendritic Cells, Thereby Modulating Cytokine Production and T Cell PrimingNicole S Armbruster, Jennifer R Richardson, Jens Schreiner, et al.Cancer Immunology Research|June 12, 2014
Microtubule-depolymerizing agents used in antibody-drug conjugates induce antitumor immunity by stimulation of dendritic cellsPhilipp Müller, Kea Martin, Sebastian Theurich, et al.Pageof 2